| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2622 |
| Trial ID | NCT04796675 |
| Disease | Chronic Lymphocytic Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 CAR-NK cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Wuhan Union Hospital, China |
| Other ID(s) | CAR-NK-CD19 cells |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||